Arkolith/Insider Trading/CLDX/Form 4

Jimenez Freddy A.

SVP & GENERAL COUNSELCelldex Therapeutics, Inc. (CLDX) · full profile →Form 4 · filed Dec 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$121K
Net Open-Market Flow
-$121K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Sell(S)4K$29.10$121K31K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001838114-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML